HCW Biologics Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from HCW Biologics Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.9 times its market value (net debt). Lower than 97% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 99%
Sales fell 99% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-99% / -48%In 3 years sales changed by -99% while total assets changed by -48%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-2.0×Operating cash was negative last year, while some debt falls due within a year.
Higher than 64% of Healthcare companies in United States.
Cash Cushion Ratio
1.9× debtDebt, after subtracting cash, is 1.9 times its market value (net debt).
Lower than 97% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
HCW Biologics Inc. made a loss over the last year. HCW Biologics Inc. owes $0.72 for every $1 it owns. HCW Biologics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossHCW Biologics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.34The share price is 0.34 times HCW Biologics Inc.'s book value per share, lower than 95% of Healthcare companies in United States.
Market cap
$3 MThe total market value of all of HCW Biologics Inc.'s shares at today's price (share price × number of shares), smaller than 96% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$7 MWhat HCW Biologics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.32Net worth divided by the number of shares. The share price of $1.12 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-151.4%HCW Biologics Inc. lost 151.4% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
Owes vs Owns
0.72×HCW Biologics Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.
Dividend yield
NoneHCW Biologics Inc. does not currently pay a dividend.
Revenue growth
-98%Revenue fell 98% in the year to Dec 2025, and shrank 80% a year on average over 3 years.
Profit growth
LossHCW Biologics Inc. made a loss in each of the last two years.
Profit margin
-14677.1%HCW Biologics Inc. lost $14677 for every $100 of revenue.
Interest cover
Not coveredHCW Biologics Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtHCW Biologics Inc. had $5 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For HCW Biologics Inc.: $3 M ÷ $7 M (30 Jun 2026) = 0.3.
What is HCW Biologics Inc.'s return on equity?
HCW Biologics Inc. lost 151.4% of its shareholders' money over the last year, lower than 80% of Healthcare companies in United States.
How much does HCW Biologics Inc. owe compared with what it owns?
HCW Biologics Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.
Does HCW Biologics Inc. pay a dividend?
No. HCW Biologics Inc. does not currently pay a dividend.
Is HCW Biologics Inc.'s revenue growing?
Revenue fell 98% in the year to Dec 2025, and shrank 80% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.